Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-12-11
2000-08-22
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546120, A61K 31435, C07D47104
Patent
active
061073059
ABSTRACT:
Compounds of the formula ##STR1## and pharmaceutically acceptable salts thereof for use as inhibitors of cyclin dependent kinases, wherein:
REFERENCES:
patent: 3755340 (1973-08-01), Hoehn et al.
patent: 3773778 (1973-11-01), Hoehn et al.
patent: 3810905 (1974-05-01), Hoehn et al.
patent: 3985757 (1976-10-01), Denzel et al.
patent: 3987051 (1976-10-01), Denzel et al.
patent: 4552883 (1985-11-01), Bare et al.
patent: 5733920 (1998-03-01), Mansuri et al.
Hohn et al., "1H-Pyrazolo[3,4-b] pyridines", J. Heterocyclic Chem., vol. 9, pp. 235-253 (1972).
Bursuker Isia
Kimball S. David
Misra Raj N.
Rawlins David B.
Webster Kevin R.
Babcock Timothy J.
Bristol--Myers Squibb Company
Dentz Bernard
LandOfFree
Use of pyrazolo [3,4-b] pyridine as cyclin dependent kinase inhi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of pyrazolo [3,4-b] pyridine as cyclin dependent kinase inhi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of pyrazolo [3,4-b] pyridine as cyclin dependent kinase inhi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-581407